Neuropeptides in skin

Journal of the American Academy of Dermatology

Volumn 33, Issue 3, 1995, Pages 482-496

  Lotti, Torello ^a   Hautmann, Giuseppe ^b   Panconesi, Emiliano ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CALCITONIN GENE RELATED PEPTIDE; GALANIN; GAMMA INTERMEDIN; NEUROPEPTIDE; NEUROTENSIN; SOMATOSTATIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ENDOTHELIUM CELL; ENTEROCHROMAFFIN CELL; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; KERATINOCYTE; NEUROMODULATION; NEUROTRANSMISSION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKIN FUNCTION;

CAPSAICIN; HUMAN; IMMUNITY, CELLULAR; NERVE FIBERS; NEUROPEPTIDES; NEUROTRANSMITTERS; RECEPTORS, NEUROPEPTIDE; SKIN; SKIN DISEASES;

EID: 0029133136     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/0190-9622(95)91395-5     Document Type: Review

References (184)

1. Overview of peptide systems with special reference to coexistence with classical transmitters
2. Distribution of neuropeptides in brain: a review of biochemical and immunohistochemical studies
3. The influence of the psyche and brain on immunity and disease susceptibility: a critical review
4. Noradrenergic sympathetic innervation of spleen and lymph nodes in relation to cellular compartments
5. Immune-neuroendocrine network
6. Stress and immunity a unifying concept
7. Interactions of glucocorticoids with macrophages
8. Specific insulin binding site on T and B lymphocytes as a marker of cell activation
9. Specific binding of growth hormone to thymocytes
10. Changes in thymic estrogen receptor expression following orchidectomy
11. H-testosterone distribution and binding in rat thymus cells in vivo
12. Regulation of lymphokine production by arginine vasopressin and oxytocin modulation of lymphocyte function by neurohypophyseal hormones
13. Modulation of immunity and hypersensitivity by sensory neuropeptides
14. Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells
15. Identification of β-a-drenoreceptors during thymocyte ontogeny in mice
16. Nicotinic acetylcholine receptor on human lymphocytes
17. Specific nonopiate receptors for β-endorphin
18. Suggestive evidence for receptors for morphine and methionine enkephalin on normal human blood T-lymphocytes
19. A molecular basis for bidirectional communication between the immune and neuroendocrine systems
20. An immunocytochemical study of cutaneous innervation and the distribution of neuropeptides and protein gene products 9.5 in man and commonly employed laboratory animals
21. Occurrence and distribution of neuropeptides in the human skin
22. Neuropeptidi e cute
23. Identificazione immunoistochimica delle fibre anxiety-peptidergiche nella cute umana normale
24. Detection of mRNA encoding proopiomelanocortin in the A431 cell line
25. An unidentified depressor substance in certain tissue extracts
26. Pharmacology of the tachykinin system
27. Structures of neuropeptides and their precursors
28. Regional distribution of substance P in the brain of the rat
29. The distribution of substance P immunoreactive fibers in the rat central nervous system
30. Distribution of substance P-like immunoreactivity in the central nervous system of the rat: I. cell bodies and nerve terminals
31. Substance P and pain: a possible relation in afferent transmission
32. Substance P: the first peptide neurotransmitter?
33. Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice
34. Characterization of spinal actions of four substance P analogues
35. 8enkephalinamide
36. Smooth muscle pharmacology of substance P
37. Substance P in peripheral sensory processes
38. Substance P as a neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation
39. Decrease of substance P in primary afferent neurons and impairment of neurogenic plasma extravasation by capsaicin
40. Post-occlusive cutaneous vasodilation mediated by substance P
41. Vascular responses of human skin to injection of substance P and mechanism of action
42. The substance P receptor on rat mast cells and in human skin
43. Are the proposed substance P receptor subtypes, substance P receptors?
44. Antipeptide antibodies that recognize a lymphocyte substance P receptor
45. Stimulation of human B lymphocyte differentiation by the neuropeptides substance P and neurokinin A
46. Pain and inflammation
47. Neuropeptides and the pathogenesis of allergy
48. Substance P provokes cutaneous erythema and edema through a histamine-independent pathway
49. Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium
50. Degranulation of human mast cells induced and endothelial antigen central to leukocyte adhesion
51. Substance P and immunoregulation
52. Neuropeptide regulation of the expression of hypersensitivity
53. Identification, purification, and characterzation of a mast cell-associated cytolytic factor related to TNF
54. Substance P primes human neutrophil activation: a mechanism for neurological regulation of inflammation
55. Comparison of substance P-induced and compound 48/80-induced neutrophil infiltrations in mouse skin
56. The potencies of substance P, substance P fragments, and compound 48/80 for granulocyte infiltration in mouse skin
57. Substance P-induced granulocyte infiltration in mouse skin the mast-cell dependent granulocyte infiltration by the N-terminal peptide is enhanced by the activation of vascular endothelial cells by the C-terminal peptide
58. Substance P recognition by a subset of human T lymphocytes
59. Substance P enhances interleukin-2 expression in activated human T cells
60. Neuropeptides and immunity
61. The cytokinelike action of substance P upon B cell differentiation
62. Substance P antagonist inhibits immediate and delayed type cutaneous hypersensitivity reactions
63. Neuropeptides in psychosomatic dermatology
64. Aspectos psicosomaticos de la dermatitis atopica
65. Neuropeptides: a meeting point between biological and mental
66. Psychoneuroimmunology of atopic dermatitis: the possible role of neuropeptides
67. Neuropeptidergic acral dysesthesia: a new entity
68. Stress, neuropeptides, and skin
69. Psychoneuro-endocrinimmunology and cancer
70. Stress, symmetry, and psoriasis: possible role of neuropeptides
71. Stress and psoriasis: psychoneuroimmunologic mechanisms
72. Neuropeptides and skin: the state of the art
73. Skin reactivity to neuropeptides in atopic dermatitis
74. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study
75. Substance P enhances the fibrinolytic system in human skin
76. Substance P regulates the vasodilator activity of calcitonin gene-related peptide
77. Specific binding of substance P in normal human keratinocytes [Abstract]
78. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products
79. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
80. Isolation and characterization of human calcitonin gene-related peptide
81. A second human calcitonin/CGRP gene
82. Two immunohistochemically identified populations of calcitonin gene-related peptide (CGRP)-immunoreactive axons in human skin
83. Calcitonin gene-related peptide (CGRP) immunoreactivity in the neuroendocrine Merkel cells and nerve fibres of pig and human skin
84. Immunocytochemical analysis of calcitonin gene-related peptide and vasoactive intestinal polypeptide in Merkel cells and cutaneous free nerve endings of cats
85. Evaluation of the in vivo and in vitro calcium-regulating actions of noncalcitonin peptides produced via calcitonin gene expression
86. Potent and comparable vasodilator actions of A- and B-calcitonin generelated peptides on the superficial subcutaneous vasculature of man
87. Calcitonin gene-related peptide is a potent vasodilator
88. Potent vasodilator activity of calcitonin gene-related peptide in human skin
89. Some effects of calcitonin gene-related peptide in human skin and on histamine release
90. Esperienze preliminari sull' attività chemiotattica del CGRP con lo skin window test
91. attività del CGRP sui granulociti neutrofili in vitro: dati indicativi di un' azione chemiotattica indiretta
92. Rapid induction of endothelial cell adhesion molecules by neuropeptides in vivo [Abstract]
93. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells
94. Inhibition of mitogen-stimulated T lymphocyte proliferation by calcitonin gene-related peptide
95. Calcitonin gene-related peptide (CGRP) inhibits Langerhans cell (LC) antigen presentation [Abstract]
96. Potent anti-inflammatory action of calcitonin gene-related peptide
97. Calcitonin gene-related peptide (CGRP) and transcutaneous electrical nerve stimulation (TENS) increase cutaneous blood flow in a musculocutaneous flap in the rat
98. Increased skin flap survival and arterial dilation by calcitonin generelated peptide
99. Vasoactive intestinal peptide and related peptides
100. Effects of glucagon, VIP, and vasopression on villous microcirculation and superior mesenteric artery blood flow of the rat
101. Influence of VIP antiserum on lower esophageal spincter relaxation: possible evidence for VIP as the inhibitory transmitter
102. Effects of VIP on blood flow motility and fluid transport in the gastrointestinal tract of the cat
103. Is VIP a neurotransmitter in the gastrointestinal tract?
104. Localization of VIP to central and peripheral nerves
105. Immunohistochemical localization of a vasodilatory peptide (VIP) in cerebrovascular nerves
106. Action of glucagon on canine left ventricular performance and coronary hemodynamics
107. Coexistence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man
108. Hyperglycemic and glycogenolytic effects of vasoactive intestinal polypeptide
109. Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter
110. VIP and the skin (Editorial)
111. Peptidergic (neurotensin, VIP, substance P) nerve fibres in the skin: immunohistochemical evidence of an involvement of neuropeptides in nociception, pruritus, and inflammation
112. VIP-immunoreactivity in skin of various mammals: immunohistochemical, radioimmunological, and experimental evidence for dual localization in cutaneous nerves and Merkel cells
113. Immunohistochemical localization of vasoactive intestinal polypeptide (VIP) in Merkel cells of various mammals: evidence for a neuromodulator function of Merkel cell
114. Evidence for PHI-immunoreactivite nerve fibres in the human skin: Coexistence with VIP?
115. Vasoactive intestinal polypeptide receptor-like immunoreactivity in human sweat glands
116. Vasoactive intestinal peptide and peptide histidine methionine (PHM) in human eccrine sweat glands demonstration of innervation specific binding sites and presence in secretion
117. Local effect of vasoactive intestinal polypeptide on human sweat gland function
118. Immunoreactivity to material like vasoactive intestinal polypeptide in epidermal cells of lichen sclerosus at atrophicus
119. Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters
120. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators
121. Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin
122. Interaction of neuropeptides with human mast cells
123. Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes
124. Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes
125. Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells
126. Modification of lymphocyte traffic by vasoactive neurotransmitter substances
127. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes by Peyer's patches, mesenteric lymph nodes, and spleen
128. The effects of VIP on human NK cell function
129. Peptidergic neurons and vasoactive intestinal peptide modulate experimental delayed-type hypersensitivity reactions
130. Coexistence of somatostatin and avian pancreatic polypeptide (APP)-like immunoreactivity in some forebrain neurons
131. Morphology, distribution, and synaptic relations of somatostatin and neuropeptide Y-immunoreactive neurons in rat and monkey neocortex
132. Neuropeptide Y: complete amino acid sequence of the brain peptide
133. Bovine pancreatic polypeptide-like immunoreactivity in brain and peripheral nervous system: coexistence with catecholaminergic nerves
134. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function
135. A detailed account of NPY-immunoreactive nerves and cells of the human skin: comparison with VIP-substance P-, and PHI-containing structures
136. Nonadrenergic prazosin resistant spanchnic vasoconstriction during immobilization stress in rat: possible role of neuropeptide Y
137. Neuropeptide Y modulates adrenergic neurotransmission by an endothelium dependent mechanism
138. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels
139. Capsaicin hot new pharmacological tool
140. Capsaicin-evoked release of substance P from primary sensory neurons
141. Local effector functions of capsaicin-sensitive sensory nerve endings: involvements of tachykinins, calcitonin gene-related peptide, and other neuropeptides
142. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin
143. Capsaicin and neurogenic inflammation: history and early findings
144. The neuropharmacology of capsaicin: review of some recent observations
145. Capsaicin and sensory neurones: a review
146. Capsaicin: a chemical probe for sensory neuron mechanisms
147. Neurophysiological effects of capsaicin
148. Capsaicin-type pungent agents producing pyrexia
149. Capsaicin-sensitive chemoceptive neural system with dual sensory efferent function
150. Responses of single nerve to capsaicin applied to the skin
151. A pharmacological approach to elucidation of the role of different nerve fibers and receptor endings in mediation of pain
152. C-fibre functions after topical application of capsaicin to a peripheral nerve and after neonatal capsaicin treatment
153. Capsaicin and cutaneous afferent
154. Vascular and sensory responses of human skin to mild injury after topical treatment with capsaicin
155. Heat and mechanical hyperalgesia induced by capsaicin: cross modality threshold modulation in human C-nociceptors
156. Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin
157. Hyperalgesia to heat after intradermal injection of capsaicin
158. Capsaicin cream in dermatology [Poster abstracts]
159. 2 in the human skin
160. Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflex
161. Topical capsaicin treatment of chronic postherpetic neuralgia
162. Treatment of chronic postherpetic neuralgia with topical capsaicin
163. Post-herpetic neuralgia and topical capsaicin
164. Capsaicin in postherpetic neuralgia
165. Treatment of aquagenic pruritus with topical capsaicin cream
166. Treatment of notalgia paresthetica with topical capsaicin
167. Notalgia paresthetica
168. Localized pruritus: notalgia paresthetica
169. The post-mastectomy pain syndrome and the effect of topical capsaicin
170. Therapeutic studies on vulvar vestibulitis
171. Pathological reactions of human skin: involvement of sensory nerves
172. Capsaicin treatment of different dermatological affections with itching [Abstract]
173. Sostanza P, capsaicina e prurito
174. Neurogenic inflammation induced by capsaicin in patients with psoriasis
175. Capsaicin: actions on nociceptive C-fibres and therapeutical potential
176. Peptide T: a new treatment for psoriasis?
177. Peptide T in treatment of AIDS
178. The major internal protein p27 of a retrovirus-like particle expressed in blood lymphocytes from psoriasis patients
179. Neuronal cells killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide
180. Digital cutaneous vascular response to histamine and neuropeptides in Raynaud's phenomenon
181. Some neuropeptides as modulators of experimental contact allergy